PMID- 21407935
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20110714
LR  - 20211020
IS  - 0019-5545 (Print)
IS  - 1998-3794 (Electronic)
IS  - 0019-5545 (Linking)
VI  - 42
IP  - 2
DP  - 2000 Apr
TI  - Rave drug (ecstasy) and selective serotonin reuptake inhibitor anti-depressants.
PG  - 195-7
AB  - 3, 4 Methylenedioxymethamphetamine (MDMA) also known as Ecstasy is a common 
      recreational drug of abuse and reports of abuse of tricyclic antidepressants are 
      also known. We report two cases of misuse of selective serotonin re-uptake 
      inhibitors (SSRIs) antidepressants in combination with Ecstasy and their 
      beneficial subjective effects experienced by misusers. We hypothesise the 
      probable underlying pharmacological reasons and recommend its use in the 
      treatment of neurotoxic effects of MDMA.
FAU - Singh, A N
AU  - Singh AN
AD  - A.N. SINGH, Consultant Psychiatrist, South Lincolnshire Healthcare NHS Trust, 
      Beaconfield Centre, Beacon Lane, Grantham Lines, NG319DF, UK.
FAU - Catalan, J
AU  - Catalan J
LA  - eng
PT  - Journal Article
PL  - India
TA  - Indian J Psychiatry
JT  - Indian journal of psychiatry
JID - 0013255
PMC - PMC2957712
OTO - NOTNLM
OT  - MDMA
OT  - SSRI's
OT  - antidepressant
OT  - treatment potential
EDAT- 2000/04/01 00:00
MHDA- 2000/04/01 00:01
PMCR- 2000/04/01
CRDT- 2011/03/17 06:00
PHST- 2011/03/17 06:00 [entrez]
PHST- 2000/04/01 00:00 [pubmed]
PHST- 2000/04/01 00:01 [medline]
PHST- 2000/04/01 00:00 [pmc-release]
AID - IJPsy-42-195 [pii]
PST - ppublish
SO  - Indian J Psychiatry. 2000 Apr;42(2):195-7.